Cowen and Company advice for Biogen
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| February 06, 2020 | Cowen and Company | Biogen | Buy | 355.00 USD | 43.36 % |
Advice details
New York - Op 06 feb herhalen de analisten van Cowen and Company hun koopadvies voor het Amerikaanse biotechnologisch bedrijf Biogen (ISIN: US09062X1037 / Mnemo: BIIB). Het 12-maands koersdoel is vastgesteld op 355.0 USD
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 